Harvey is a Cardiologist and Director of the Green Lane Cardiovascular Research Unit, Te Toka Tumai Auckland, Te Whatu Ora – Health New Zealand . He is an Honorary Professor of Medicine University of Auckland and Fellow of the Royal Society of New Zealand.  Harvey trained at Green Lane Hospital, Auckland and Harvard and Brigham and Women’s Hospital, Boston. He is the John Neutze Scholar awarded by the Green Lane Research and Education Fund.

In recognition of his work on end-systolic volumes as the most important modifiable prognostic factor following myocardial infarction (MI). This is recognised in the top ten advances in coronary care management (Braunwald), he was awarded DSc by Otago University. He was awarded the Prince Mahidol Award (Nobel Prize of the East) by the King of Thailand for introducing fibrinolytic therapy in developing countries, including China. He is a Matai (La’uli) in Samoa for services to Samoa, and has a “pou” in the Te Awamutu Walk of Fame recognising his contribution to decreasing heart disease in New Zealand.

He is Co-chairman of the Redefinition of Myocardial Infarction Consensus group and defined the 5 types of MIs. He is senior author on the Bleeding Academic Consortium (BARC) to define bleeding.  He has been a member of numerous guideline groups including the NZ guidelines group defining absolute risk. He is a member of the Cholesterol Treatment Trialists’ (CTT) Collaboration and is on 16 editorial Boards. He has over 1000 publications and 77 editorials with an H Score of 121.

He gave the most prestigious International Society and Federation of Cardiology lecture at the European Society of Cardiology in 1993, and Paul Dudley White lectures at the American Heart Association in 2004 and at American College of Cardiology in 2011. Harvey is recognised in the top 1% of scientists worldwide and No 5 for publication of RCT-related articles in all high-impact-factor medical journals over the past five decades. He was also awarded the highest collaboration index. 

He has been NZ Chairman and President of the combined Cardiac Society of Australia and New Zealand and has given the Kempson Maddox lecture and been recipient of the Ralph Reader prize for outstanding research. He was awarded the Inaugural Gold Medal at the Cardiac Society of Australia and New Zealand Annual Scientific Meeting 2019 for outstanding contribution to Cardiology in New Zealand.

He was on the board of the New Zealand Medical Association from 2008 to 2021, Chairman of the Specialist Council from 2009 to 2018 and deputy Chairman from 2017 to 2021.

He introduced the 10 year earlier screening for Maori in the absolute risk assessment and  has presented to the Health committee on doing that for colonic screening; published on  worse outcomes for Maori after bypass surgery; has a Pou in the Te Awamutu rose gardens; and as deputy of the NZMA introduced the Maori byline for the New Zealand Medical association.

He has made multiple visits to Samoa doing clinics, including a WHO visit and report, attending the 50th annual meeting of the Samoan Medical association, and a matai title La’auli, the highest mountain, for services to Samoa.

He has been a strong advocate for the wider availability of Automated External Defibrillators (AEDs) in New Zealand.

Publications